IL2 and cancer: In a six-h assay, NK-92MI cell line, which produces a membrane-bound IL-2, can kill ten cancer cells serially.287 The authors noted that the first kill was slower than subsequent ones and that if cells are denser, the following killings are executed more rapidly, suggesting possible simultaneous killings.